Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid × nilotinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Leukemia, Myeloid, Chronic-Phase 2 Synovitis, Pigmented Villonodular 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

venetoclax 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Interleukin-2 2 Cyclophosphamide 2 Busulfan 2 ponatinib 1 asciminib 1 Photography 1 IPI-549 1 Bone Marrow Transplantation 1 Biopsy 1 Azacitidine 1 14-O-phosphonooxymethyltriptolide disodium salt 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡